These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26171227)

  • 1. Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells.
    Huang JX; Kaeslin G; Ranall MV; Blaskovich MA; Becker B; Butler MS; Little MH; Lash LH; Cooper MA
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00148. PubMed ID: 26171227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
    Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
    Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole.
    Udawatte NS; Kang SW; Wang Y; Arumugam TV; Seneviratne CJ
    Front Pharmacol; 2020; 11():511. PubMed ID: 32390849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of osteopontin as an early nephrotoxicity indicator in human renal proximal tubule cells and its application in evaluating lanthanum-induced nephrotoxicity.
    Chen Y; Xu F; Xiao X; Chi H; Lai Y; Lin X; Li Q; Song J; Wu W; Li Z; Yang X
    Ecotoxicol Environ Saf; 2024 Feb; 271():115928. PubMed ID: 38215666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of biomarkers for
    Qiu X; Miao Y; Geng X; Zhou X; Li B
    Toxicol Res (Camb); 2020 Apr; 9(2):91-100. PubMed ID: 32440340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
    Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
    BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An
    Qiu X; Zhou X; Miao Y; Li B
    Toxicol Res (Camb); 2018 Nov; 7(6):1205-1213. PubMed ID: 30510689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin production negatively correlates with HK-2 cell impairment: Evaluation of NGAL as a marker of toxicity in HK-2 cells.
    Hauschke M; Roušarová E; Flídr P; Čapek J; Libra A; Roušar T
    Toxicol In Vitro; 2017 Mar; 39():52-57. PubMed ID: 27888128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of kidney injury in preeclampsia: Increased maternal and urinary levels of NGAL and KIM-1 and their enhanced expression in proximal tubule epithelial cells.
    Wang Y; Gu Y; Gu X; Cooper DB; Lewis DF
    Front Med (Lausanne); 2023; 10():1130112. PubMed ID: 37089603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity.
    Bajaj P; Chung G; Pye K; Yukawa T; Imanishi A; Takai Y; Brown C; Wagoner MP
    Toxicology; 2020 Sep; 442():152535. PubMed ID: 32622972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.
    Mishra J; Mori K; Ma Q; Kelly C; Barasch J; Devarajan P
    Am J Nephrol; 2004; 24(3):307-15. PubMed ID: 15148457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats.
    Fuchs TC; Mally A; Wool A; Beiman M; Hewitt P
    Vet Pathol; 2014 May; 51(3):680-94. PubMed ID: 23912714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
    van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
    Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
    Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
    Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
    Ichimura T; Hung CC; Yang SA; Stevens JL; Bonventre JV
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F552-63. PubMed ID: 14600030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs.
    Chebotareva N; Grechukhina K; Mcdonnell V; Zhukova L; Krasnova T
    Biomed Rep; 2022 Jun; 16(6):46. PubMed ID: 35620307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.